Features of Steroid-Induced Adrenal Insufficiency
Steroid-induced adrenal insufficiency presents with nonspecific symptoms including fatigue, nausea, vomiting, and anorexia, and is characterized biochemically by low or intermediate morning cortisol (5-10 µg/dL) with low or inappropriately normal ACTH levels, distinguishing it from primary adrenal insufficiency. 1
Clinical Presentation
Common Symptoms
- Fatigue occurs in 50-95% of patients with adrenal insufficiency and is the most frequent presenting complaint 1
- Nausea and vomiting affect 20-62% of patients, often accompanied by poor appetite and weight loss 1
- Anorexia and weight loss occur in 43-73% of cases, representing significant glucocorticoid deficiency 1
- Morning nausea and lack of appetite are particularly common and may indicate under-replacement of glucocorticoids 2
Gastrointestinal Features
- Nonspecific gastrointestinal symptoms are common presenting features after steroid withdrawal or tapering 3
- Periumbilical abdominal pain may occur, particularly in acute presentations 4
- Vomiting can be prominent and contributes to electrolyte disturbances 4
Cardiovascular Manifestations
- Unexplained hypotension should raise immediate suspicion for adrenal insufficiency in any patient taking ≥20 mg/day prednisone or equivalent for at least 3 weeks 2
- Hypotension may progress to shock if untreated, representing adrenal crisis 1
Laboratory Features
Cortisol and ACTH Patterns
- Low or intermediate morning cortisol levels (5-10 µg/dL) are characteristic, distinguishing steroid-induced from primary adrenal insufficiency which typically shows cortisol <5 µg/dL 1
- ACTH levels are low or inappropriately normal (not elevated as in primary adrenal insufficiency), confirming central suppression of the hypothalamic-pituitary-adrenal axis 1, 5
- Low DHEAS levels accompany the low cortisol and ACTH 1
Electrolyte Abnormalities
- Hyponatremia is present in 90% of newly diagnosed adrenal insufficiency cases, making it a highly sensitive marker 2, 4
- Hyperkalemia is notably ABSENT in steroid-induced adrenal insufficiency because aldosterone secretion is preserved (unlike primary adrenal insufficiency where it occurs in ~50% of cases) 6, 4
- If vomiting is present, hypokalemia may occur instead of hyperkalemia due to gastrointestinal losses masking any tendency toward hyperkalemia 4
- Hypoglycemia may occur, particularly during acute illness or stress 6
Metabolic Features
- Hypercalcemia is a rare but well-documented complication of glucocorticoid-induced adrenal insufficiency, occurring when steroids are withdrawn 5
- Metabolic acidosis may be present in severe cases 6
Diagnostic Considerations
Key Distinguishing Features from Primary Adrenal Insufficiency
- Absence of hyperpigmentation (no elevated ACTH to stimulate melanocytes) 6
- Preserved aldosterone function (no hyperkalemia or significant salt wasting) 4
- Low or normal ACTH rather than elevated 1, 5
- No associated autoimmune conditions typically seen with primary adrenal insufficiency 2
Confounding Factors
- Exogenous steroids including oral prednisolone, dexamethasone, and inhaled fluticasone confound interpretation of cortisol levels and must be considered when interpreting diagnostic tests 6, 2
- Morning cortisol measurements in patients currently on corticosteroids are not diagnostic, as therapeutic steroids may cross-react in cortisol assays 6
- Hydrocortisone must be held for 24 hours and other steroids for longer before endogenous adrenal function can be accurately assessed 6
Routes of Steroid Administration That Cause HPA Suppression
All Routes Can Suppress the HPA Axis
- Oral corticosteroids are the most common cause, particularly doses ≥20 mg/day prednisone equivalent for ≥3 weeks 6, 2
- Inhaled corticosteroids (particularly fluticasone) can suppress the HPA axis even at commonly prescribed doses in a dose-dependent manner 6, 7
- Intra-articular steroid injections can cause systemic absorption and subsequent HPA axis suppression, with recovery occurring within 2 weeks to months 3
- Intrathecal steroid administration has been documented to cause secondary adrenal insufficiency, with elevated steroid levels persisting in cerebrospinal fluid for up to 2 months 8
- Topical, intranasal, and intrabursal routes can all potentially suppress the HPA axis 6
Time Course and Recovery
Duration of HPA Suppression
- HPA axis suppression may persist for up to 12 months after discontinuation of therapy following large doses for prolonged periods 9
- Recovery of the HPA axis should be tested after 3 months of maintenance hydrocortisone therapy 6
- In some cases, recovery can occur as quickly as 2 weeks after diagnosis, though this is variable 3
Risk Factors for Prolonged Suppression
- Higher doses of glucocorticoids increase risk 6
- Longer duration of therapy increases risk 6
- Potent synthetic glucocorticoids (dexamethasone, betamethasone) carry higher risk than hydrocortisone 6
Critical Clinical Pitfalls
Common Diagnostic Errors
- Do not rely on the absence of hyperkalemia to exclude adrenal insufficiency—it is absent in steroid-induced cases and present in only ~50% of primary adrenal insufficiency 6, 4
- Do not assume normal electrolytes exclude the diagnosis—10-20% of patients have normal electrolytes at presentation 2
- Do not attempt laboratory confirmation of adrenal insufficiency in patients currently on high-dose corticosteroids until treatment is ready to be discontinued 6
- The threshold to test for adrenal insufficiency should be low in any patient with nonspecific symptoms after steroid use or withdrawal 3
Management Imperatives
- Treatment of suspected acute adrenal insufficiency should NEVER be delayed for diagnostic procedures if the patient is clinically unstable 6, 2
- If unstable, give 100 mg IV hydrocortisone immediately without waiting for test results 2, 4
- If diagnosis is uncertain but testing is still needed, use dexamethasone 4 mg IV instead of hydrocortisone, as dexamethasone does not interfere with cortisol assays 2
- All patients require education on stress dosing, emergency injectable steroids, and should wear medical alert identification 6, 1